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We evaluated all ABCC6 missense variants from ClinVar, from 
literature and novel variants from in-house patient screenings. 
In total, 234 variants were analysed using the numerical 
score-based variant classification system Sherloc (Nykamp et 
al. 2017). Clinical and functional evidence were scored with 
benign (B) or pathogenic (P) points using hierarchical decision 
trees. Classification was based on the variant’s total score: 
benign (class 1), likely benign (class 2), variants of uncertain 
significance (VUS) (class 3), likely pathogenic (class 4) and 
pathogenic (class 5). To distinguish between different types of 
VUS we created additional subclasses: those that are truly 
uncertain (3 U) and those leaning towards likely benign (3 LB) 
or likely pathogenic (3 LP) (Fig 1a).
Methodology
Findings
Comprehensive classification revealed that 74% of ABCC6 missense variants are class 3 
(Fig 2). (Likely) pathogenic variants account for 12% (class 4) and 9% (class 5) respectively, 
almost all of which are located in the protein’s functional domains. (Likely) benign variants 
are the least represented (1% and 3% respectively). VUS classification was further refined 
into those that lean towards likely benign (1% of class 3), those that are truly uncertain (69% 
of class 3) and those that lean towards likely pathogenic (30% of class 3) based on their 
total score (inset Fig 2).
Taking the latter also into account, 43% of ABCC6 variants is (likely) pathogenic when 
considering all available population, clinical, experimental and in silico data (Fig 3). This is 
significantly different from the variant database ClinVar, where 87% of ABCC6 missense 
variants are said to be pathogenic and only 11% are VUS.
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Introduction
Pseudoxanthoma elasticum (PXE) is an ectopic mineralization disorder affecting the 
elastic fibers of the skin, the eye and the cardiovascular system. It is caused by biallelic 
mutations leading to loss-of-function of the ABCC6 gene. To date, over 400 genetic 
variants have been reported in ABCC6. However, high phenotypic variability, a lack of 
genotype-phenotype correlations and contemporary population genomics raise the 
question whether all these variants are pathogenic. Especially for missense substitutions it 
is challenging to predict the impact on protein function (Fig 1b). We therefore re-evaluated 
ABCC6 missense variants and classified them according to pathogenicity.
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Fig 2: ABCC6 missense variants classified according to 
pathogenicity (total variants = 234). Inset: subclassification of 
class 3 variants into class 3 with likely benign (LB), likely 
pathogenic (LP)  or unclear (U) tendency (in percentage of 
total class 3 variants). 
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Conclusions
Evaluation of ABCC6 missense variants using the most recent and comprehensive criteria 
reveals an overestimation of (likely) pathogenic variants in literature and databases. 
Data that are missing for many variants are experimental validation and - surprisingly - 
segregation data. Our results underline that variant classification should be done 
systematically and with caution, as variant interpretation has important consequences for 
patients and carriers identified via familial or expanded carrier screening. The high 
number of VUS confirms the need for functional testing to prove or refute their causality 
before returning them to patients. 
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Fig 1: (a) Evaluation and scoring of clinical and functional evidence leads to classification of 
the variant based on its total score. (b) Effect of genetic variation on the protein function. 
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Fig 3: Distribution of (likely) benign (class 1 + 2 + 3 LB), 
uncertain (class 3 U) and (likely) pathogenic (class 3 LP + 4 + 
5) ABCC6 missense variants.
